TGFB1 and cholangiocarcinoma: As the results shown, tumor immune response involved pathways, such as TGF-β signaling pathway, T cell receptor signaling pathway, and leukocyte trans-endothelial migration pathway were changed followed by the differential expression of APOB in CCA.